Methyl 4-chloropyrimidine-5-carboxylate

Catalog No.: 
ACMCUH820
CAS No.: 
1246471-45-3
Molecular Formula: 
C6H5ClN2O2
Molecular Weight: 
172.57
Methyl 4-chloropyrimidine-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$74.00In stockInquiry
1g98%$180.00In stockInquiry
5g98%$555.00In stockInquiry
10g98%$888.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-chloropyrimidine-5-carboxylate
IUPAC Namemethyl 4-chloropyrimidine-5-carboxylate
MDL No.MFCD12964314
Molecular FormulaC6H5ClN2O2
Molecular Weight172.57
SMILESO=C(C1=CN=CN=C1Cl)OC
InChI KeyQJLKRVYFYNEGKY-UHFFFAOYSA-N
SynonymMethyl 4-ChloropyriMidine-5-carboxylate;5-Pyrimidinecarboxylic acid, 4-chloro-, methyl ester
CAS No.1246471-45-3
PubChem CID44631873

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMCUH820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMCUH820 route product structure diagram
    ACMCUH8201246471-45-3In Stock
Inquiry

2. ACMCUH820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMCUH820 route product structure diagram
    ACMCUH8201246471-45-3In Stock
Inquiry

3. ACMCUH820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKMQW152 route compound structure diagram
    ACKMQW1523177-20-6In Stock
  2. Then
  3. ACMCUH820 route product structure diagram
    ACMCUH8201246471-45-3In Stock
Inquiry

Comments (0)